메뉴 건너뛰기




Volumn 40, Issue 37, 2011, Pages 9580-9588

Pharmaceutical formulation affects titanocene transferrin interactions

Author keywords

[No Author keywords available]

Indexed keywords

ANTICANCER ACTIVITIES; ANTICANCER DRUG; CHARGE TRANSFER ENERGY; CLINICAL TRIAL; DFT CALCULATION; FLUORESCENCE QUENCHING; FT-ICR MASS SPECTROMETRY; HUMAN SERUM TRANSFERRIN; MOLAR ABSORPTIVITY; PH-DEPENDENT; PHARMACEUTICAL FORMULATION; PHASE I; PHASE II; SYNERGISTIC ANIONS; TITANOCENE DICHLORIDE; TITANOCENES;

EID: 80052750603     PISSN: 14779226     EISSN: 14779234     Source Type: Journal    
DOI: 10.1039/c1dt10805k     Document Type: Article
Times cited : (14)

References (57)
  • 6
    • 80052693001 scopus 로고    scopus 로고
    • Master of Science thesis, Queen's University, Kingston, Ontario, Canada
    • J. R. Boyles, Master of Science thesis, Queen's University, Kingston, Ontario, Canada, 1997
    • (1997)
    • Boyles, J.R.1
  • 21
    • 80052701887 scopus 로고    scopus 로고
    • US Pat., 5296237, 1994
    • US Pat., 5296237, 1994


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.